AAAAAA

   
Results: 1-8 |
Results: 8
ROLE OF IL-10 IN THE ABNORMALITIES OF EARLY CELL ACTIVATION EVENTS OFLYMPHOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: GONZALEZAMARO R PORTALESPEREZ D BARANDA L ABUDMENDOZA C LLORENTE L RICHAUDPATIN Y ALCOCERVARELA J ALARONSEGOVIA D
Citation: R. Gonzalezamaro et al., ROLE OF IL-10 IN THE ABNORMALITIES OF EARLY CELL ACTIVATION EVENTS OFLYMPHOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Journal of autoimmunity (Print), 11(5), 1998, pp. 395-402
PENETRATING ANTI-DNA MONOCLONAL-ANTIBODIES INDUCE ACTIVATION OF HUMANPERIPHERAL-BLOOD MONONUCLEAR-CELLS
Authors: PORTALESPEREZ D ALARCONSEGOVIA D LLORENTE L RUIZARGUELLES A ABUDMENDOZA C BARANDA L DELAFUENTE H TERNYNCK T GONZALEZAMARO R
Citation: D. Portalesperez et al., PENETRATING ANTI-DNA MONOCLONAL-ANTIBODIES INDUCE ACTIVATION OF HUMANPERIPHERAL-BLOOD MONONUCLEAR-CELLS, Journal of autoimmunity (Print), 11(5), 1998, pp. 563-571
LONG-TERM METHOTREXATE THERAPY IN SYSTEMIC LUPUS-ERYTHEMATOSUS WITH RENAL INVOLVEMENT
Authors: ABUDMENDOZA C CUEVAS E GONZALEZAMARO R
Citation: C. Abudmendoza et al., LONG-TERM METHOTREXATE THERAPY IN SYSTEMIC LUPUS-ERYTHEMATOSUS WITH RENAL INVOLVEMENT, Arthritis and rheumatism, 41(9), 1998, pp. 463-463
ABNORMALITIES IN CD69 EXPRESSION, CYTOSOLIC PH AND CA2-ERYTHEMATOSUS(DURING ACTIVATION OF LYMPHOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS)
Authors: PORTALESPEREZ D GONZALEZAMARO R ABUDMENDOZA C SANCHEZARMASS S
Citation: D. Portalesperez et al., ABNORMALITIES IN CD69 EXPRESSION, CYTOSOLIC PH AND CA2-ERYTHEMATOSUS(DURING ACTIVATION OF LYMPHOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS), Lupus, 6(1), 1997, pp. 48-56
ABNORMALITIES IN CD69 EXPRESSION, CYTOSOLIC PH AND CA2-ERYTHEMATOSUS (SLE)(, DURING ACTIVATION OF LYMPHOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS)
Authors: PORTALESPEREZ D SANCHEZARMASS S ABUDMENDOZA C GONZALEZAMARO R
Citation: D. Portalesperez et al., ABNORMALITIES IN CD69 EXPRESSION, CYTOSOLIC PH AND CA2-ERYTHEMATOSUS (SLE)(, DURING ACTIVATION OF LYMPHOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS), Journal of investigative dermatology, 108(4), 1997, pp. 591-591
HYPOTHALAMUS-HYPOPHYSIS-THYROID AXIS DYSFUNCTION IN PATIENTS WITH REFRACTORY FIBROMYALGIA
Authors: ABUDMENDOZA C MAGANAAQUINO M MEDINA R GRIMALDO JI RODRIGUEZRIVERA G GONZALEZAMARO R
Citation: C. Abudmendoza et al., HYPOTHALAMUS-HYPOPHYSIS-THYROID AXIS DYSFUNCTION IN PATIENTS WITH REFRACTORY FIBROMYALGIA, Arthritis and rheumatism, 40(9), 1997, pp. 947-947
PLASMA-LEVELS AND IN-VITRO PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 IN PATIENTS WITH AMEBIC LIVER-ABSCESS
Authors: GONZALEZAMARO R ANDRADE S BARANDA L ABUDMENDOZA C PORTALES DP MONCADA B LLORENTE L
Citation: R. Gonzalezamaro et al., PLASMA-LEVELS AND IN-VITRO PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 IN PATIENTS WITH AMEBIC LIVER-ABSCESS, Revista de Investigacion Clinica, 46(3), 1994, pp. 209-213
METHOTREXATE THERAPY IN CHILDHOOD SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: ABUDMENDOZA C STURBAUM AK VAZQUEZCOMPEAN R GONZALEZAMARO R
Citation: C. Abudmendoza et al., METHOTREXATE THERAPY IN CHILDHOOD SYSTEMIC LUPUS-ERYTHEMATOSUS, Journal of rheumatology, 20(4), 1993, pp. 731-733
Risultati: 1-8 |